X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 21st March, 2019 on account of Holi.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8%
Fri, 24 Aug

ORCHID PHARMA LTD has announced its results for the quarter ended March 2018. Here is a detailed performance review of the same:

ORCHID PHARMA LTD Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-17*
3
Dec-17*
3
Mar-18*
QoQ ChangeYoY Change
Net SalesRs m2,0491,4421,5588.0%-24.0%
Other incomeRs m868414-83.1%-83.5%
TurnoverRs m2,1341,5261,5723.0%-26.4%
ExpensesRs m1,9921,3062,27273.9%14.0%
Gross profitRs m-521136-714-625.0%
DepreciationRs m349335326-2.7%-6.7%
InterestRs m1,2137620-100.0%-100.0%
Profit before taxRs m-1,997-877-1,025
TaxRs m-119-105-101
Profit after taxRs m-1,879-772-924
Gross profit margin%-25.49.4-45.8
Effective tax rate%5.911.99.9
Net profit margin%-88.0-50.6-58.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 24.0% on a year-on-year (YoY) basis. The expenses were up by 14.0% YoY during the same period.
  • The company's operating profit increased by 37.0% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 45.8% in 4QFY18 as against 25.4% in 4QFY17.
  • Depreciation charges and finance costs declined by 6.7% YoY and 100.0% YoY, respectively.
  • Other income declined by 83.5% YoY during the quarter.
  • Net profit for the quarter increased by 50.8% YoY. Net profit margins during the quarter increased from -88.0% in 4QFY17 to -58.8% in 4QFY18.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.0% on a quarter-on-quarter (QoQ) basis. The expenses were up by 73.9% QoQ during the same period.
  • The company's operating profit declined by 625.0% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 45.8% in 4QFY18 as against 9.4% in 3QFY17.
  • Net profit for the quarter declined by 19.6% QoQ, while net profit margins declined from -50.6% in 3QFY17 to -58.8% in 4QFY18.

To see how ORCHID PHARMA LTD has performed over the last eight quarters, please visit here.

ORCHID PHARMA LTD Share Price Performance

Over the last one year, ORCHID PHARMA LTD share price has moved up from Rs 20.2 to Rs 7.6, registering a Loss of Rs 12.7 or around 62.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,410.4 (down 0.1%). Over the last one year it has moved up from 13,226.3 to 15,410.4, a gain of 2,184 points (up 16.5%).

Overall, the S&P BSE SENSEX is up 21.5% over the year.

Current Valuations

At the current price of Rs 7.6, the price to book value (P/BV) ratio of ORCHID PHARMA LTD stands at 0.2 times.

Equitymaster requests your view! Post a comment on "ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8%". Click here!

  

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Mar 20, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 5-YR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS